NASDAQ:BSGM BioSig Technologies (BSGM) Stock Price, News & Analysis → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free BSGM Stock Alerts $1.86 -0.16 (-7.67%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Today's Range$1.85▼$1.9950-Day Range$0.63▼$2.4052-Week Range$0.26▼$15.50Volume75,000 shsAverage Volume730,181 shsMarket Capitalization$23.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get BioSig Technologies alerts: Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About BioSig Technologies Stock (NASDAQ:BSGM)BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Read More BSGM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSGM Stock News HeadlinesMay 30, 2024 | globenewswire.comBioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMay 21, 2024 | globenewswire.comBioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to ShareholdersMay 3, 2024 | globenewswire.comBioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 IndependentApril 30, 2024 | marketwatch.comBioSig Technologies Appoints Amato as CEO Following Engagement With Consulting FirmApril 30, 2024 | globenewswire.comBioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective ImmediatelyApril 18, 2024 | thestreet.comBioSig Technologies Inc.April 10, 2024 | msn.comAptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies among healthcare moversApril 8, 2024 | msn.comU.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.03%April 4, 2024 | finance.yahoo.comBioSig Engages Consulting Firm for Business Model StrategiesApril 4, 2024 | globenewswire.comBioSig Engages Consulting Firm for Business Model StrategiesFebruary 29, 2024 | investing.comBiosig Technologies Inc (BSGM)February 23, 2024 | msn.comU.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.13%February 22, 2024 | benzinga.comBioSig Technologies Stock (NASDAQ:BSGM) Earnings Dates and Earning CallsFebruary 21, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.13%February 20, 2024 | finance.yahoo.comBioSig Announces Reduction of its WorkforceFebruary 20, 2024 | globenewswire.comBioSig Announces Reduction of its WorkforceFebruary 7, 2024 | msn.comBioSig Technologies Marks 100 Cases with Tracking AlgorithmFebruary 6, 2024 | stockhouse.comBioSig's PURE EP(TM) Platform with New Near Field Tracking Algorithm Surpasses 100 Patient CasesFebruary 6, 2024 | finance.yahoo.comBioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient CasesFebruary 2, 2024 | msn.comBioSig Technologies Slashes Workforce, Halves Cash BurnFebruary 2, 2024 | msn.comBioSig Technologies Announces Executive Team RestructuringJanuary 30, 2024 | finance.yahoo.comBioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core StrategyDecember 30, 2023 | benzinga.comBioSig Technologies Stock (NASDAQ:BSGM) Dividends: History, Yield and DatesDecember 12, 2023 | finance.yahoo.comShareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's WhyDecember 8, 2023 | morningstar.comBioSig Technologies Inc BSGMSee More Headlines Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/31/2022Today6/09/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:BSGM CUSIPN/A CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,040,000.00 Net MarginsN/A Pretax Margin-91,566.66% Return on Equity-8,129.09% Return on Assets-951.37% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.14 Sales & Book Value Annual Sales$20,000.00 Price / Sales1,163.76 Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-5.65Miscellaneous Outstanding Shares12,480,000Free Float11,316,000Market Cap$23.28 million OptionableOptionable Beta0.84 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Frederick D. Hrkac (Age 58)President, Principal Executive Officer, Executive VP & Director Mr. Anthony Amato (Age 56)CEO & Director Dr. Budimir S. Drakulic Ph.D. (Age 74)Chief Scientist Comp: $169.64kMr. Andrew Gornell BallouVice President of Investor RelationsKey CompetitorsRockwell MedicalNASDAQ:RMTIFONARNASDAQ:FONRVivani MedicalNASDAQ:VANIHyperfineNASDAQ:HYPRCuteraNASDAQ:CUTRView All CompetitorsInsiders & InstitutionsPFG Investments LLCSold 51,454 shares on 4/22/2024Ownership: 0.948%Kenneth L LondonerBought 600 shares on 6/12/2023Total: $7,020.00 ($11.70/share)View All Insider TransactionsView All Institutional Transactions BSGM Stock Analysis - Frequently Asked Questions How have BSGM shares performed in 2024? BioSig Technologies' stock was trading at $4.75 at the beginning of the year. Since then, BSGM stock has decreased by 60.7% and is now trading at $1.8650. View the best growth stocks for 2024 here. Are investors shorting BioSig Technologies? BioSig Technologies saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 461,700 shares, a drop of 10.2% from the April 30th total of 514,300 shares. Based on an average daily volume of 1,120,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 4.6% of the shares of the company are short sold. View BioSig Technologies' Short Interest. When is BioSig Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our BSGM earnings forecast. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) posted its quarterly earnings results on Thursday, March, 31st. The company reported ($2.40) EPS for the quarter, missing analysts' consensus estimates of ($2.20) by $0.20. When did BioSig Technologies' stock split? BioSig Technologies's stock reverse split before market open on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU). Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include PFG Investments LLC (0.95%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy. View institutional ownership trends. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BSGM) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.